Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity

OBJECTIVES: Acyclovir is approved to treat herpes simplex virus (HSV) type 1, type 2 and varicella-zoster virus. It is mainly eliminated via the kidneys, for which drug crystals accumulation might lead to nephrotoxicity. This study aimed to determine the incidence, risk factors, preventive measures,...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Alawi, Abdullah M., Al-Maqbali, Juhaina Salim, Al-Adawi, Maria, Al-Jabri, Anan, Falhammar, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257855/
https://www.ncbi.nlm.nih.gov/pubmed/35812148
http://dx.doi.org/10.1016/j.jsps.2022.03.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257855/
https://www.ncbi.nlm.nih.gov/pubmed/35812148
http://dx.doi.org/10.1016/j.jsps.2022.03.013

Ejemplares similares